This year, more than 175,000 people in the U.S. will be diagnosed with a blood cancer, such as lymphoma, leukemia, or myeloma. Dr. Caron Jacobson, Medical Director, Immune Effector Cell Therapy Program at Dana-Farber Cancer Institute, joins me to discuss potentially life-saving therapy treatment options for patients with certain difficult-to-treat or advanced blood cancers.
